Clinical Trial Update: Safety and Efficacy Study of Oral Glycopyrrolate Liquid for the Treatment of Pathologic (Chronic Moderate to Severe) Drooling in Pediatric Patients 3 to 18 Years of Age With Cerebral Palsy or Other Neurologic Conditions [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating oral glycopyrrolate liquid for treating pathologic drooling in children with cerebral palsy or other neurologic conditions; study compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Palsy
• Sialorrhea

Drugs mentioned

• Glycopyrrolate (glycopyrrolate)

Snippet

Sponsor: Shionogi | Conditions: Cerebral Palsy, Neurological Conditions | Phase 3 | Status: COMPLETED | Results posted: 2012-07-09